Get started
Author

Sara Charmsaz

EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
2013 · Bryan W. Day, Brett W. Stringer, et al. · Cancer Cell · 221
PDF
Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference
2019 · Sara Charmsaz, Denis Collins, et al. · Cancers · 82
PDF
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma
2016 · Brett W. Stringer, Jens Bunt, et al. · Oncotarget · 45
PDF
Innovative Technologies Changing Cancer Treatment
2018 · Sara Charmsaz, Maria Prencipe, et al. · Cancers · 42
PDF
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
2018 · Alacoque L. Browne, Sara Charmsaz, et al. · Oncogene · 40
PDF
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1
2011 · Bryan W. Day, Brett W. Stringer, et al. · Neuro-Oncology · 39
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia
2016 · S Charmsaz, F Al-Ejeh, et al. · Leukemia · 37
PDF
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
2021 · Damir Varešlija, Elspeth Ward, et al. · Oncogene · 30
PDF
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors
2017 · Sara Charmsaz, Andrew M. Scott, et al. · Experimental Hematology · 30
S100β as a serum marker in endocrine resistant breast cancer
2017 · Sara Charmsaz, Éamon Hughes, et al. · BMC Medicine · 29
PDF
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB
2020 · Manikandan Periyasamy, Anup K. Singh, et al. · Oncogene · 27
Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
2018 · Elspeth Ward, Damir Varešlija, et al. · Clinical Cancer Research · 26
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
2015 · Sara Charmsaz, Kirrilee Beckett, et al. · PLoS ONE · 22
PDF
ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
2020 · Sara Charmsaz, Ben Doherty, et al. · BMC Medicine · 19
PDF
An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
2022 · Preeti Borde, Nicola Cosgrove, et al. · Cancer Gene Therapy · 16
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study.
2025 · Samer Ali Srour, Jad Chahoud, et al. · Journal of Clinical Oncology · 15
PDF
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版 · 11
PDF
Eph receptors as oncotargets
2017 · Sara Charmsaz, Andrew W. Boyd · Oncotarget · 9
PDF
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy
2021 · Rachel Bleach, Stephen F. Madden, et al. · Clinical Cancer Research · 8
Expression and Function of the Eph Receptor Family in Leukemia and Hematopoietic Malignancies: Prospects for Targeted Therapies
2013 · Sara Charmsaz · Journal of Leukemia · 8
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
2023 · B. Ffrench, E. Kashdan, et al. · Heliyon · 7
PDF
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
2026 · Samer A. Srour, Jad Chahoud, et al. · Journal of Clinical Oncology · 3
PDF
EphA3 As a Target For Monoclonal Antibody Therapy For Acute Leukemia
2013 · Sara Charmsaz, Kirrilee J Miller, et al. · Blood · 2
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
2022 · Preeti Borde, Nicola Cosgrove, et al. · Cancer Gene Therapy · 1
PDF
O28: M6a Demethylase Fto a Potential Target in Brain Metastatic Breast Cancer
2021 · S Keelan, S Charmsaz, et al. · British journal of surgery · 1
PDF
Works count: 67
Citation count: 771
H-index: 15
I10-index: 17
Year
Topic
Type